The FDA said "an extensive scientific review" found the products were found to pose lower risks of cancer and other serious health conditions compared to cigarettes and smokeless tobacco products.

The U.S. Food and Drug Administration (FDA) has officially authorized the sale of Zyn nicotine pouches, a significant milestone in the tobacco industry's efforts to offer alternatives to traditional smoking products.

The agency found Zyn’s benefit as a safer alternative for adult cigarette smokers outweighs its risk to young people.